Biotecnika is India's Largest BioSciences Portal visited by 1 Million Biotech enthusiasts every month. Subscribe to our newsletter to stay updated about latest in the biotech industry

1. February 20th, 2018.
SCHOLARSHIPS - PAGE 3 NEWS - PAGE 8 NEW JOBS AVAILABLE
PAGES 9-12
ADMISSIONS - PAGE 2
PH.D. PROGRAMME (BIOLOGICAL SCIENCES)
– 2018 @ S. N. BOSE NATIONAL CENTRE
FOR BASIC SCIENCES
TRANSLATIONAL RESEARCH AWARD IN
INFECTIOUS DISEASES (TRAIN)
@ THSTI | APPLICATIONS INVITED
BRISTOL-MYERS SQUIBB, SIRENAS PEN
MULTI-TARGET COLLAB AGREEMENT
apply for the CCMB
Summer Training
Programme – 2018
internships &
ADMISSIONS
CSIR SUMMER TRAINING PROGRAMME
CCMB SUMMER TRAINING
PROGRAMME – 2018
MSc students from any science background
are encouraged and eligible to apply for the
CCMB Summer Training Programme – 2018.
Eligibility Qualifications:
The training program is open to students
from all branches of sciences and open to all
Indian Universities/Research Institutes.
• M.Sc. Program : Students admitted in
year 2017 and will complete their 1st
year in June/July 2018
• 4 Year B.Tech. Program : Students ad-
mitted in year 2015 and will complete
their 6th Semester in June/July 2018.
• 5 year Integrated B.Tech.-M.Tech. or
MBBS course : Students admitted in
year 2014 and will complete their 8th
Semester in June/July 2018; MBBS
students in any year of their study can
apply.
M. Tech. students are not eligible.
Computer science students with flair for
biology may also apply.
Training Program:
It is not a conventional classroom lectures
based training program. Instead, each se-
lected candidate/trainee will be assigned to
a CCMB staff scientist who will supervise/
mentor him/her during the stay. Each student
is expected to execute a small project work
under the guidance of the scientist. At the end
of the program, student will need to submit a
‘Project Report’ of the work done, and also
would be required to make an oral presenta-
tion. The program is mainly intended to give
students a real-time exposure/hands-on expe-
rience to a research environment, in the hope
that it would inculcate in them a zeal for re-
search as a future career.
Although, efforts are made to take into
consideration the ‘statement of purpose’/re-
search interest of the selected students (while
assigning to different Scientists), but it is
generally not possible in many cases; as the
allotments are mainly based on the availabil-
ity of working place(s) in different labs and
not the other way around. Therefore, only
those students should apply for the training
program who are ready to work in any labo-
ratory of CCMB, if selected, irrespective of
his/her stated research interest.
Selection Process:
A committee nominated by the Director,
CCMB, selects the trainees. One of the major
criteria used in selection is that the selected
candidates should represent the Nation-wide
coverage of different Indian states (based on
the location of their academic institutions,
but independent of their birthplace, sex, cast
or religion). ‘Statement of purpose’ and the
Vol. 02 NO 8
1
GET THIS NEWSPAPER e-copy VIA WHATSAPP every week
GIVE MISSED CALL TO
080-395-34707
‘Recommendation/reference Letter’ are other
important considerations in the selection of
candidates along with the academic record.
A few seats (~5%) are reserved, each for the
children of serving CCMB employees, and
for candidates selected by the AcSIR.
The number of trainees’ intake varies be-
tween 50 – 60 candidates, and mainly de-
pends upon the availability of bench space
with different staff scientists of CCMB. On
an average, we receive ~1500 applications, of
which only 3 – 4% candidates make it to the
program.
Application Procedure:
Application for the Summer Program 2018
can be downloaded (Zipped pdf file- https://
www.biotecnika.org/2018/02/ccmb-sum-
mer-training-programme-2018/). Complet-
ed application (Hard copy) for the program
MUST reach CCMB by 28/2/2018. The names
of the Selected candidates will be made avail-
able on CCMB homepage during the second
week of April 2018 (around 15/4/2018); here,
it may be noted that no separate intimation
would be sent to any candidate, and thus all
applicants must look for his/her name in the
‘selection list’on the CCMB homepage only.
Support / Boarding / Lodging:
CCMB will not provide any financial sup-
port for boarding/ lodging. All the selected
candidates are required to self-finance their
stay in CCMB/Hyderabad. The candidates
are expected to make their own arrangement
for stay in Hyderabad during the training pe-
riod, though CCMB may consider specific
Next Page>>>>
By Diluxi Arya

2. Vol. 02 NO 8February 20th, 2018.
2
requests only from outstation students, es-
pecially girl students for shared accommo-
dation in CCMB housing facility depending
upon the availability of vacant flats/space.
Important Points:
• As is evident from our experience in
earlier years, the competition is very
high for the few available seats with an
average chance of selection being only
3 – 4%.
• Applications for Summer Program
2018 MUST be submitted as a hard
copy. The application incomplete in
any respect will be rejected/not consid-
ered.
• Requests/applications for the program
sent prior to this notification will not be
considered. Any such candidate must
apply again using the prescribed appli-
cation form.
• There is no FEE for the training pro-
gram; but all selected candidates have
to bear their boarding/lodging expend-
iture during the 60-day stay at CCMB.
• The decision of the Selection commit-
tee about the selection of candidates
shall be final.
• Canvassing in any form and/or bringing
in any influence, political or otherwise,
will be treated as a disqualification.
• Selected candidates are expected to
have cleared their final exams (1st year
in case of M.Sc. students, 6th semes-
ter in case of B.Tech. students and 8th
semester in case of 5 year Integrated
B.Tech- M.Tech. students) before join-
ing the program and thus are required
to bring the documentary proof for the
same. On the other hand, for students,
whose results may be awaited at that
time, students would need to provide a
certificate from their college certifying
that – the student has appeared for the
final exams, and that the results are yet
to be declared.
• All candidates selected for the program
will need to spend a minimum period of
60 days in CCMB without any break.
• This is one of the most important re-
quirements and accordingly, all candi-
dates need to furnish a certificate from
their Head of the Department/Compe-
tent authority of the
• college/institute to this effect (see the
Application form for instructions).
Mailing address for application:
Dr. Arvind Kumar
Coordinator
Summer Program 2018
Centre for Cellular & Molecular Biology
(CCMB)
Uppal Road,
Habsiguda
Hyderabad-500007 (Telangana)
Please mention on top of the envelope
MSc candidates with first class in Biophys-
ics or Biochemistry with valid CSIR-NET-
JRF/ UGC-NET-JRF / INSPIRE-JRF (Pro-
visionally awarded) are eligible to attend the
walk-in interview for the PhD Admissions in
Biological Sciences at S. N. Bose National
Centre for Basic Sciences.
The S. N. Bose National Centre for Basic
Sciences, a premier autonomous research in-
stitute fully aided by the Department of Sci-
ence and Technology, Government of India
invites eligible candidates with consistently
good academic record (First Division/Class)
to appear in the walk-in interview for admis-
sion into the Ph.D Programme in Physical,
Chemical & Biological Sciences for the Aca-
demic Year 2017-18.
Overview:
The programme is fully residential and
the students are offered on-campus accom-
modation and boarding facilities. The Cen-
tre charges no fee for the programme. All
students joining the centre get contingency
grants to meet research contingency expens-
es that include expenses for attending confer-
ences and training programmes in India. The
students also get generous support to attend
International Conferences outside India from
the Centre.
The Centre has extensive collaborative re-
search programmes with other premier In-
ternational & National institutions through
bi-lateral exchanges in which the PhD re-
To tackle health needs of the country, to
reach the marginalized population in remote
areas, technology can become a huge enabler
in ensuring delivery of quality and affordable
healthcare. Indeed, technology can potential-
ly enable overcoming the complex challeng-
es faced in ensuring accessible, affordable
and appropriate healthcare to all.
The Indian Council of Medical Research
(ICMR), New Delhi, the apex body in India
for the formulation, coordination and promo-
tion of biomedical research, is one of the old-
est medical research bodies in the world. The
Council has 33 institutes around the country
working on priority diseases and regional
problems. Besides this there are 12 Model
Rural Health Research Unit (MRHRU). Each
of the MRHRU’s is linked with one of the
ICMR institution/centre for mentoring and is
located in close proximity to the state health
facility (Community / Primary Health Cen-
tre at block level). It is headed by an au-
thorized officer of the concerned mentoring
INTERNSHIPS & ADMISSIONS
Ph.D. Programme
(Biological Sciences) –
2018 @ S. N. Bose
National Centre for
Basic Sciences
search scholars take active part. The Centre
receives various extramural funds from dif-
ferent funding agencies of India and abroad
for its different research programmes. The
Centre is fully equipped with the state-of-the
art infrastructure (experimental and computa-
tional) including digital library for advanced
research in chosen areas of Physical, Chem-
ical, Biological and Mathematical Sciences.
For research profiles of the Faculty members
and facilities available at the Centre, please
visit the URL: www.bose.res.in. At present,
the Centre has nearly 160 students in its PhD
and Integrated PhD (IPhD) programmes. The
Alumni of the Centre have gone on to work
in academic and research sectors in India
and abroad. The Centre offers an excellent
atmosphere for academic development of
students. The students, after registering with
a Research Supervisor, have to undertake a
prescribed Course Work Programme as per
existing UGC regulations.
The details of the admission procedure
are furnished below:
Basic Qualification:
a) M.Sc. with First Class/Division i.e., min-
imum 60% in aggregate (55% for SC/ST/
OBC
candidates) in Physics, Chemistry, Applied
Mathematics, Biophysics or Biochemistry.
b) Valid CSIR-NET-JRF/ UGC-NET-JRF /
INSPIRE-JRF (Provisionally awarded).
Age Limit :
None. However, the last Qualifying Uni-
versity examination (M.Sc.) should have
been taken not earlier than 2015.
Fellowship :
In line with the rules of Funding Agency
(CSIR/UGC/INSPIRE).
Admission Procedure:
• Aspiring candidates are advised to ap-
pear for Walk-in interview.
• Please bring a plain paper CV with
your testimonials giving 10th, 12th,
Bachelors and Masters degree details
and valid award letter from funding
agency.
• In matter of admission, the decision of
the Director of the Centre is final and
binding.
For any academic/official query, please
write to: admission@bose.res.in
For any technical query, please write to:
admission-help@bose.res.in
Walk-in Interview Date : 21st and 22nd
February, 2018, Reporting Time : 9:30 am
ICMR-IITKGP- IIMA Med
Tech Internship Award
(Summer 2018)
ICMR Institute/Centre. Also, the scientists/
faculty from ICMR institutes are deployed at
MRHRUs.
Indian Institute of Technology Kharagpur
(IITKGP) is the first IIT to start a School of
Medical Science & Technology and a super
specialty hospital with technology devel-
opment focus is coming up fast in the cam-
pus. Currently, about forty faculty members,
drawn from different departments are work-
ing on more than twenty five projects in this
area that involve physicians, life science do-
main experts of collaborating institutions.
Indian Institute of ManagementAhmedabad
(IIMA) has consistently been ranked as one
of the best management schools in the coun-
try year after year in the last several years.
Centre for Management of Health Services
(CMHS) was setup in June 2004 in recogni-
tion of IIMA’s contributions to the health sec-
tor in the past and the felt need to strengthen
the management of health sector in the con-
text of socio-economic developments of our
country. The overall objectives of CMHS are
to address the managerial challenges in the
delivery of health services to respond to the
needs of different segments of our population
efficiently and effectively, build institutions
of excellence in the health sector, and influ-
ence health policies and wider environments.
IIM Ahmedabad’s Centre for Incubation and
entrepreneurship (CIIE) helps entrepreneurs
turn ideas into viable businesses by incu-
bating, accelerating, mentoring and funding
innovative start-ups. CIIE believes that en-
trepreneurship has an unmatched ability to
bring disruptive changes in healthcare and
affordable technology in India.
Aim of the Internship Award :
The primary aim of ICMR- IIT Kharag-
pur-IIM Ahmedabad MedTech Internship
Award is to promote individuals for under-
taking research in the fields of biomedical
engineering and translational research in
healthcare.
Duration of Internship Award :
8 weeks, extendable up to 10 weeks in
special situations Number of Internships :
Next Page>>>>
“Application for Summer Training 2018”
Important Dates:
The program is for duration of 60 days
(~eight weeks) in the months of May-July
2018.
Last date for receipt of Application in
CCMB : 28 February 2018.
List of the selected candidates on CCMB
homepage : Second week of April 2018.
(There will NOT be any separate letter of
intimation to the selected candidates)
Last date for selected candidates to inform
their:
Acceptance to CCMB/Program Coordina-
tor : 20 April 2018
Tentative date to join CCMB/the program :
10-15th May 2018
(No candidate will be allowed to join
after 23rd May under any circumstance)

3. Vol. 02 NO 8 February 20th, 2018.
3
Next Page>>>>
IIT Kharagpur, IIM Ahmedabad and ICMR
Institutes will support around 20 students for
internship program. However the exact num-
bers will depend on the appropriateness of
the applications.
Applications are invited for Summer
2018 MedTech Internship Program
About Internship Program
With an aim to encourage cross-disciplinary
interaction of young students / researchers of
medical, engineering and business domain,
under the ICMR-IITKGP and ICMR-IIMA
MoU, a student exchange program has been
introduced. This student-student interaction
is expected to enrich either side and make the
team come up with new ideas and solution
strategy on a given healthcare challenge.
The students will get a first hand experi-
ence of developing innovative technologies
to meet the health needs of the country. A
part of the internship period will be spent at
RMRC, Bhuvaneshwar’s mentored MRH-
RU, Tigiria, Cuttack (Govt of Odisha) linked
to the SCB Medical College, Cuttack. The
MRHRU and medical college will act as
‘Live Healthcare Laboratories’ for medical
technology need assessment, development,
testing and validation with ICMR institute
faculty acting as mentors. IIT Kharagpur fac-
ulty will guide the interns through the process
of technology development whereas the IIM
Ahmedabad faculty will help in mentoring
the business development part of technology.
The medical-technology-business intern
team will work in a strategic area of health
and observe the clinical facility, shadow the
physician, frontline health worker and/or
a patient for a period of around 1 week at
MRHRU, Tigiria and/or SCB Medical Col-
lege, Cuttack. This will be followed by inten-
sive training for technology development at
ICMR institute, IIT Kharagpur and IIM Ah-
medabad laboratories. The observations col-
lected during their stay at MRHRU/medical
college will be useful in building new ideas
or reshaping the initial project proposal from
a set of project ideas with which interns start-
ed their application process. The team along
with mentors and students of host institutes
will brainstorm all the possible ways in which
the need can be addressed. The mentors and
mentee will then come up with priority areas
where medical technology/ healthcare sys-
tem model is needed. The teams will then
focus on design and development of proof
of concept and possible early level prototype
at an earlier identified ICMR institute, IIT
Kharagpur or IIM Ahmedabad.
At the end of the internship, a report will
be submitted by the intern. Three to four of
the best designs will be selected and provid-
ed support for development of prototype at
ICMR/IITKharagpur/IIM Ahmedabad and
IIM Ahmedabad incubator.
The interns will also be trained in evaluation
of the IP, regulatory compliance, stakeholder
validation, methodology for preclinical and
clinical testing of the prototype or methodol-
ogy for validation of the health system model
and marketing strategy.
Who can apply?
Students undertaking MBBS, clinical post-
graduate degree courses (e.g., M.D., DNB)
or Ph.D. students in clinical/life sciences
subjects from ICMR institutes or medical
colleges/ Scientist B working at ICMR insti-
tutes will be working with fellow engineering
and business management interns and other
students in the labs of the IIT Kharagpur and
Centre for Management of Health Services
(CMHS), IIM Ahmedabad for short dura-
tions. Vice a versa, individuals undertaking
BE/ BTech (in a stream of engineering with a
potential of having impact on health through
technology), engineering postgraduate de-
gree courses (MTech), PhD (engineering)
from IIT Kharagpur, MBA students from
IIM Ahmedabad will be provided support for
a supervised internships at the ICMR insti-
tute/medical college. The applicants will be
required to provide names of a mentor from
their institute.
The internship period of 8-10 weeks is
spread over May – June, 2018. It can be ex-
tended to Dec. 2018 if and only if there is a
requirement in the parent institute of the in-
tern for which documentary evidence needs
to be produced.
Awards
IIT Kharagpur, IIM Ahmedabad and ICMR
Institutes will support around 20 students for
internship program.
• Students who are not getting stipends
(e.g. MBBS, B Tech, MBA etc) : Sti-
pend of Rs 40,000/- will be provided
for 8-10 week period. (Rs 20,000/- per
month). Accommodation will be pro-
vided free by the host institute. No ex-
tra travel allowance will be paid.
• Students who are getting monthly sti-
pend (e.g. MD, MTech, PhD students)
will be provided Rs 20,000/- for food
and travel.
• Scientist B from ICMR institute will
meet expensed for TA/DA through in-
stitution budget.
At the end of the internship, a report will be
submitted by the intern. Three of the best de-
signs will be selected and provided a budget
of Rs 2 lakhs maximum each for develop-
ment of prototype within next one year. This
budget can be used for consumables, travel,
and small equipment (not exceeding 15% of
entire budget).
How to Apply:
The application is to be made online
(http://14.139.60.56/medtech/ or http://icmr.
nic.in/). After sign up, one can download an
offline version of the form which might help
in getting the application material ready to
complete the online application process.
Date of Commencement of Internship
May 07, 2018 (Monday)
Application Due Date : 26th February
2018
SCHOLARSHIPS
TRAIN is a post-doctoral research program
initiated by THSTI to impart training in trans-
lational research to candidates with doctoral
degree in biological sciences. Selected can-
didates will be involved in large infectious
disease research programs/projects involving
human cohorts/clinical trials and are expect-
ed to work at the interface of biology and
clinical research. Candidates will be jointly
mentored by biologists and clinical research-
ers during the course of their fellowship. The
focus areas include epidemiology, immunol-
ogy, pathogenesis, drug and vaccine develop-
ment, and diagnostics for viral and bacterial
diseases (Eg: Dengue, Hepatitis, Pneumonia,
Tuberculosis etc.,).
Essential Qualifications:
Ph.D in biological sciences with at least
one research article in a peer-reviewed jour-
nal indexed in PUBMED as first author.
The JC Bose fellowship is awarded to active
scientists in recognition for their outstanding
performance. The fellowship is scientist-spe-
cific and very selective.
Eligibility
Should be an active scientist with a record
of outstanding performance apparent from
the award of SS Bhatnagar prize and/or fel-
lowship of science academies (including en-
gineering, agriculture and medicine).
The scientist should be in service at the time
of nomination to this fellowship.
The nominee should be an Indian national
working in institutions/Universities in India.
Translational Research
Award in INfectious
Diseases (TRAIN)
@ THSTI | Applications
Invited
SERB – JC Bose
Fellowship Program :
2018 | Get Fellowship of
Rs 25,000/- pm +
Research Grant of
Rs.15.00 Lakh pa
Candidates who have submitted their thesis
and are waiting for the award of the degree
may also apply. However they should have
an accepted first-author publication at the
time of application.
Desirable Qualifications:
Doctoral research in the areas of infectious
diseases, immunology, and microbiology
with exposure to clinical research. Expertise
in handling human clinical samples, animal
models of disease and in vitro assays relevant
to infectious disease research.
Age:
30 years or less.
Emoluments: Rs. 60,000/- per month con-
solidated in the first two years with perfor-
mance-based revision in emoluments after
second year.
Period:
3-5 years depending on the annual perfor-
mance reviews
How to Apply:
Interested candidates are requested to sub-
mit the online application on or before the last
date. Applications will be screened and can-
didates will be interviewed up to four times
in a year (January, April, July and October)
depending on the number of applications.
Deadline for applications for each quarter:
March 31st, June 30th, Sept 30th, Dec 31st.
All results will be published on our website
and all future communications will be only
through email.
Canvassing in any form will be a disquali-
fication
Call for applications will remain open till
suitable candidates are found.
The procedure for online application:
a. Before filling online application, do keep
the following documents handy:
i. A soft copy of your passport size photo.
ii. A statement indicating your research in-
terests and career goals (max. 500 words)
b. Candidates are requested to use Google
Chrome internet browser for best results
in submission of online application.
c. Once online application is submitted, no
correction/modification is possible.
d. In case of difficulty in filling up the on-
line form, please contact personnel@thsti.
res.in
e. On successful submission of your appli-
cation, an auto-generated email containing
a reference number will be sent to the email
address provided. Please keep a note
of the reference number for future corre-
spondence’
f. It is mandatory to fill all fields in the on-
line application form. Incomplete applica-
tions will be rejected and no correspondence
will be entertained with such applicants

4. Vol. 02 NO 8February 20th, 2018.
4
Duration
The duration of the fellowship will be ini-
tially for five years. In case, the fellow super-
annuates during the term of the fellowship,
the fellowship can be continued if a host in-
stitution is willing to host the fellowship.
The tenure of the fellowship may be extend-
ed for subsequent term of 5 years based on
rigorous assessment of research performance
during the tenure of the fellowship. A mini-
mum of 25% of the applicants seeking exten-
sion will not be granted extension.
The fellowship can be availed up to 68
years of age.
Nature of Support
The fellowship amount is Rs. 25,000 per
month in addition to regular income.
Research grant of Rs. 15.00 lakh per annum.
Overhead of Rs.1.00 lakh per annum to the
host institute.
Nomination
The nominations can be sent by the Heads
of the Institutions; JC Bose Fellows and Pres-
idents of National science academies.
The nominations are received throughout
the year.
Selection
Selection of JC Bose Fellows will be made
periodically (normally twice a year) by a
Search-cum-Selection Committee specially
constituted for the purpose, as per the broad
guidelines of the fellowship scheme
Online Application Procedure
For successful online submission of the ap-
plication the following points may be noted:
• Nominator should first register into the
online website. click here to register
• After log-in, go to Menu –> Proposal
Submission –> Form Submission.
• Some of the details of Nominee like
Name,email,contact details, area of
specialization,educational qualifica-
tions, employment details & research
experience etc. have to be entered at the
time of submission.
• Research Contribution in Last 5 years
of the Nominee has to be uploaded in
single PDF file not more than 10 MB.
Documents required (in PDF) should be
in prescribed format:
• Recommendation Letter
Contact person Details:
The contact details of Programme Officers
are given below:
Dr. Pravakar Mohanty, Scientist ‘C’
Science and Engineering Research Board
5 & 5A, Lower Ground Floor,
Vasant Square Mall,Plot No. A, Community
Centre,
Sector-5, Pocket-5, Vasant Kunj
New Delhi-110070
Tel : +91-11-40000382
Email : p.mohanty@serb.gov.in
Frequently Asked Questions:
Q1: For whom the J.C. Bose Fellowship is
meant for?
A1: The J.C. Bose Fellowship is meant to
recognize active scientists for their outstand-
ing performance. The fellowship is scien-
tist-specific and very selective.
Q2: What are the eligibility criteria for ap-
plying/availing J.C. Bose Fellowship?
A2:
• Should be an active scientist with a
record of outstanding performance ap-
parent from the award of SS Bhatna-
gar prize and/or fellowship of science
academies (including engineering, ag-
riculture and medicine).
• The scientist should be in service at the
time of nomination to this fellowship.
• The nominee should be an Indian na-
tional working in institutions in India.
Q3: What are the areas covered under J.C.
Bose Fellowship?
A3: All Areas of Science (in the broadest
terms) are covered by this Fellowship.
Q4: What is the nature of support for the
J.C. Bose Fellow?
A4: The J.C. Bose Fellow will receive per-
sonnel Fellowship of Rs.25,000/- per month
and a Research Grant of Rs.15.00 Lakh per
annum. Rs.1.00 Lakh is provided as Over-
heads for the host institute.
Q5: What is the upper age limit up to which
the J C Bose fellowship can be availed?
A5: 68 years.
Q6: Can the JC Bose fellow continue the
fellowship after superannuation?
A6: The JC Bose fellowship can be con-
tinued after superannuation provided a host
institution is willing to accept the fellowship
and provide all necessary infrastructure and
administrative support.
Q7: When can a person apply for the J.C.
Bose Fellowship? What is the last date of ac-
ceptance of the application?
A7: The nominations for the J.C. Bose Fel-
lowship are accepted throughout the year and
there is no last date of acceptance of the nom-
ination.
O8:Who can nominate for J C Bose Fel-
lows?
A8: Heads of Institutions, JC Bose fellows,
Presidents of Science Academies can send
the nominations.
Q9: What is the duration of the J.C. Bose
Fellowship?
A9: The J.C. Bose Fellowship duration is 5
years.
Q10: How/When can the individual start his
J.C. Bose Fellowship?
A10: A letter is sent by the Science & En-
gineering Research Board to the Individual
as well as to the host Institute informing the
award of J.C. Bose Fellowship. On receipt of
this offer letter, the Individual has to send ac-
ceptance letter indicating the month when he/
she wants to start the Fellowship, and then the
Institute will forward the acceptance letter to
the Science & Engineering Research Board.
Based on this letter, the Board will process
for necessary approvals and a Sanction Or-
der will be issued to the host institute (and
a copy to the J.C. Bose Fellow). When the
grant money is received at the host institute,
the J.C. Bose Fellow can start his Fellowship.
Q11: How does a J.C. Bose Fellow get his
subsequent Grant?
A11: The Grant for the subsequent years is
released after receiving Statement of Expend-
iture (SE) and Utilization Certificate (UC) in
the prescribed format (available in the web-
site). The SE and UC are to be submitted fi-
nancial year wise i.e. from 01st April to 31st
March. For the first year it would be from the
Date of Start (DOS) to 31st March and subse-
quently from 01st April to 31st March.
Q12: Is the personal fellowship received in
J.C. Bose Fellowship scheme taxable?
A12: Yes, it is taxable.
Q13 : Can a fellow change the host institute
during implementation of J.C. Bose Fellow-
ship?
A13: A J C Bose fellow can change the host
institute during implementation of J.C. Bose
Fellowship. He has to forward NOCs from
both the Institutes along with final financial
papers indicating balance unspent grant from
the old institute and appointment letter from
the new Institute indicating the joining date
and duration of the appointment.
Q14: What are the guidelines for superan-
nuated fellows availing of the JC Bose fel-
lowship along with any other fellowship/
honorarium?
A14: Superannuated JC Bose fellows can
avail the award money provided for SS Bhat-
nagar Prize/Academy fellowships and hon-
orarium/salary being provided by the host
institution in addition to JC Bose fellowship.
However, they are not allowed to avail any
other fellowship of a similar kind such as
DAE Raja Ramanna Fellowship. Any mis-
information in this regard may lead to full
recovery of J C Bose fellowship with penal
interest from the awardees.
Q15:Is there a provision for extension of the
fellowship?
A15:
• The fellowship can be renewed for
a period of 5 years after rigorous as-
sessment of research performance of
the fellow during the tenure of the fel-
lowship. The fellows will be required
to submit a document highlighting the
research work done during the previous
5 years, with complete list of publica-
tions/patents, and manpower trained
during the tenure of the fellowship.
The criteria for renewal will be based
on research performance. Any other ac-
complishment such as occupying lead-
ership position will not be counted as
factors.
• Minimum exit of 25% of the fellows
will be enforced while giving the ex-
tension of the fellowship.
Q16 : Is there a flexibility to utilize the re-
search grant?
A16 : A J C Bose fellow can change the host
institute during implementation of J.C. Bose
Fellowship. He has to forward NOCs from
both the Institutes along with final financial
papers indicating balance unspent grant from
the old institute and appointment letter from
the new Institute indicating the joining date
and duration of the appointment

5. Vol. 02 NO 8 February 20th, 2018.
5
NEWS
Cancer “Vaccine” Beats
Tumours in Mice, All Set
for Human Trials
In a First, Scientists Grow
Human Eggs to Maturity
in Lab
It has recently become apparent that the
immune system can cure cancer. In some
of these strategies, the antigen targets are
pre-identified and therapies are custom-made
against these targets. In others, antibodies are
used to remove the brakes of the immune sys-
tem, allowing pre-existing T cells to attack
cancer cells.
Similarly, in the most recent attempt to bat-
tle cancer, researchers at the Stanford Uni-
versity School of Medicine have designed a
“Vaccine”, which, when injected into a tumor
triggers the immune system to kill cancer in
mice.
According to this new study, injecting
minute amounts of two immune-stimulating
agents directly into solid tumors in mice can
eliminate all traces of cancer in the animals,
including distant, untreated metastases.
“When we use these two agents together,
we see the elimination of tumours all over
the body,” said senior researcher, oncologist
Ronald Levy. “This approach bypasses the
need to identify tumour-specific immune tar-
gets and doesn’t require wholesale activation
of the immune system or customisation of a
patient’s immune cells.”
Out of the two immune “agents” used in
the study, published in the journal Science
The rapid pace of research in the areas
of fertility and reproduction raises some
mind-boggling questions about the future.
Now, in this direction, scientists studying
fertility have had a breakthrough- they were
able to grow precursors to human eggs to full
maturity outside the body for the first time in
a fascinating study.
The breakthrough could eventually help
women preserve their fertility after cancer
treatment, or help those with naturally occur-
ring infertility.
Scientists removed egg cells from ovary tis-
sue at their earliest stage of development and
grew them to the point at which they were
ready for fertilisation, according to the study
published in Molecular Human Reproduc-
tion.
“Apart from any clinical applications, this
is a big breakthrough in improving under-
standing of human egg development,” Evelyn
Telfer, a developmental biologist and co-au-
thor of the paper describing the study that’s
been on since the past 30 years.”
Scientists have previously developed mouse
Translational Medicine, one has already been
approved for use in humans and the second is
currently involved in a lymphoma treatment
trial.
In Levy’s two-step cancer vaccine, a short
stretch of DNA called a CpG oligonucleotide
was first injected into the tumor site.
CpG is something called a Toll-like recep-
tor, a special kind of immune system protein
that recognizes invading pathogens. When
micrograms of this protein (millionths of a
gram) were injected into the mouse tumors,
they activated the expression of a receptor
called OX40 on nearby T cells that had origi-
nally swarmed to the tumor site, but had been
rendered inactive.
The second injection contained an anti-
body that attached to those newly activated
OX40 receptors and essentially turned the
T cells back “on.” Before their activity was
suppressed, those same T cells were primed
to respond to the precise antigens produced
by the tumor. With a boost from the vaccine,
now they were back in action.
Once the process is under way, the scientists
report, the tumour-hungry T cells leave the
initial site and distribute through the body,
attacking any and all other similar tumours
they find.
“Our approach uses a one-time application
By Disha Padmanabha
By Disha Padmanabha
eggs to produce live offspring and matured
human eggs from a late stage of development.
But this study is the first time a human egg
has been developed in the laboratory from its
earliest stage to full maturity, researchers say.
In the course of this study, researchers from
Edinburgh and New York describe how they
took ovarian tissue from 10 women in their
late twenties and thirties and, over four steps
involving different cocktails of nutrients, en-
couraged the eggs to develop from their ear-
liest form to maturity.
They carefully extracted the fragile, imma-
ture eggs and some surrounding cells from
the follicles, and allowed them to further ma-
ture on a special membrane in the presence of
more growth-supporting proteins. In the end,
just nine of these eggs passed the final test for
maturity—they were able to divide and halve
their chromosomes so they were ready to join
with sperm during fertilization.
“Being able to fully develop human eggs
in the lab could widen the scope of available
fertility treatments,” said Prof Evelyn Telfer.
“We are now working on optimising the con-
ditions that support egg development in this
way and studying how healthy they are. We
also hope to find out, subject to regulatory
approval, whether they can be fertilised.”
Prof Daniel Brison, of the department of re-
production at the University of Manchester,
said it was “an exciting breakthrough which
shows for the first time that complete devel-
opment of human eggs in the laboratory is
possible, more than 20 years after this was
achieved in mice.
“As the authors acknowledge, there is much
more important research still to do, but this
could pave the way for fertility preservation
in women and girls with a wider variety of
cancers than is possible using existing meth-
ods.”
of very small amounts of two agents to stimu-
late the immune cells only within the tumour
itself,” explains Levy. “In the mice, we saw
amazing, body-wide effects, including the
elimination of tumours all over the animal.”
The team trialled the therapy against several
different types of cancers in mice- the first
involved 90 animals with lymphoma tumours
on both sides of their bodies- in each, only
one tumour was treated. The paper details
that 87 out of the 90 were cured. The cancer
returned in three cases, but went into perma-
nent remission after a second treatment.
Mice carrying breast, colon and melanoma
tumours were also treated successfully. Trials
were also conducted on mice genetically en-
gineered to develop multiple breast cancers.
In many cases treating the first tumour to ap-
pear prevented others arising.
“This is a subject that we are still investi-
gating in the animal models where we can
track T cells by a variety of different meth-
ods that are not possible in humans,” Levy
explains.
Although the researchers are optimistic of
using this approach to treat all kinds of can-
cer where T cells have infiltrated the tumor,
Levy says that they will start with lymphoma
because “it is the cancer of the immune sys-
tem and most likely to respond to this maneu-
ver.” To that end, a trial is already underway
designed to investigate the effectiveness of
the technique in 15 patients with low-grade
lymphoma.
If it’s effective, the treatment may be used
in the future on tumours before they’re surgi-
cally extracted to help prevent metastases, or
even prevent recurrences of the cancer.
“I don’t think there’s a limit to the type of tu-
mour we could potentially treat, as long as it
has been infiltrated by the immune system,”
Levy said.

6. Vol. 02 NO 8February 20th, 2018.
6
Stem Cell-Mediated,
Functional Human Kidney
Grown Inside of a Live
Organism for the First
Time
The mammalian kidney generates and elim-
inates waste products and is essential for life.
Annually, 2.6 million people worldwide re-
ceive dialysis or kidney transplantation for
end-stage kidney disease (ESKD), while
around 2.2 million people with ESKD die
prematurely, unable to access treatment.
In hopes to remedy this dire situation, sci-
entists at the University of Manchester have,
for the first time, developed fully functional
human kidney tissue which possesses the ca-
pability of producing urine within mice using
stem cells.
The study led by Professors Sue Kimber and
Adrian Woolf from The University of Man-
chester signifies a significant milestone in the
development of treatment for chronic kidney
disease, a long-term condition where the kid-
neys don’t work as well as they should, af-
fecting the lives of sufferers in various ways.
Researchers at the university, headed by
Prof. Sue Kimber started off with human
embryonic stem cells grown in a culture
By Disha Padmanabha
broth specifically designed for kidney de-
velopment. They then turned these cells into
microscopic kidney pieces. They further en-
couraged the cells to into forming the kidney
glomeruli.
These are small units that form the basic fil-
tration components of the kidney. They were
created in petri dishes by growing the stem
cells in a nutrient broth that contained all the
molecules needed to push them down the
path to forming the glomeruli.
These cells were then combined with a gel
in order to form a scaffolding to hold the
glomeruli together, and act in effect like the
connective tissue in real kidneys. The tissue
clumps were then injected under the skin of
mice with their immune systems repressed so
as to accommodate these tiny clumps of for-
eign tissue, and allowed to develop.
A final observation, three months later
showed that nephrons had appeared, includ-
ing many of the associated structures, from
proximal and distal tubules to Bowman’s
capsule and the Loop of Henle. The team
showed that fluorescent dye, injected into the
mice, was being filtered from the blood and
into the kidney tubules.
“The tubule’s job is to selectively reabsorb
key molecules, mainly salts but also things
like glucose, to stop them being wasted, and
we saw that as well,” added Professor Kim-
ber. “It’s not equivalent to a kidney – we only
had a few hundred nephrons and a human
kidney has millions – but it has all the ele-
ments from blood flow in, up to the exit at the
ureter – which takes the urine away.”
“We have proved beyond any doubt these
structures function as kidney cells by filtering
blood and producing urine – though we can’t
yet say what percentage of function exists,”
said Professor Kimber. “What is particular-
ly exciting is that the structures are made of
human cells which developed an excellent
capillary blood supply, becoming linked to
the vasculature of the mouse. Though this
structure was formed from several hundred
glomeruli, and humans have about a million
in their kidneys – this is clearly a major ad-
vance.
“It constitutes a proof of principle- but
much work is yet to be done.”
Fruit Fly Genome Sheds
Light on the Process of
Aging
rDNA loci, composed of hundreds of tan-
demly duplicated arrays of rRNA genes, are
known to be among the most unstable genetic
elements due to their repetitive nature. rDNA
instability underlies aging (replicative senes-
cence) in yeast cells, however, its contribu-
tion to the aging of multicellular organisms is
poorly understood.
The latest study from University of Michi-
gan Life Sciences Institute aims to understand
this very mechanism using genome of fruit
flies. The study investigates the dynamics of
rDNA loci during aging in the Drosophila
male germline stem cell (GSC) lineage, and
show that rDNA copy number decreases dur-
ing aging.
Certain sections of the fruit fly genome get
shorter with age. But remarkably, some re-
productive cells can repair the shrinkage, and
this genomic shrinkage may underlie aspects
of aging and hint at ways that select cells
might thwart it.
In the study, Yukiko Yamashita and her col-
leagues focused on workhorse genes encoded
in ribosomal DNA, or rDNA. The cells, to
make enough of these mission-critical ma-
chines, require huge loads of rDNA instruc-
tion manuals. Most genes are limited to a
single genetic location, but rDNA genes are
repeated across multiple spots of the genome.
“The end result is that some copies are
lost every cycle,” says Yamashita, research
professor at the University of Michigan’s
Life Sciences Institute and professor of cell
By Disha Padmanabha
and developmental biology at the university.
“They are popping out of the chromosome.”
In fruit flies, chains of rDNA genes are
found on the X and Y chromosomes. Com-
pared with young male fruit flies, old males
had a shortage of rDNA genes on the Y chro-
mosome­—leaving them with a shrunken Y
chromosome, the researchers discovered.
Further, the team also came across how this
dearth of rDNA seemed to be passed on from
generation to generation.
Geriatric fly fathers (those 40 days old)
passed on their reduced number of rDNA
genes to their sons, the team observed. These
sons had considerably fewer copies of rDNA
genes than sons born to younger fathers.
Then came the shocker- they noticed how
this rDNA loss reversed itself. At about 10
days of age, sons born to old fathers had re-
covered enough rDNA to be comparable to
sons born to young fathers. The results sug-
gest that rDNA rejuvenation in sons might
be a crucial aspect of how stem cells persist
from father to son.
Though much more work remains, Yamash-
ita suspects that similar resets might be at
work in certain kinds of human cells, includ-
ing stem cells and cancer cells.
“Of course, we are not flies,” she says. But
if pushed to bet, she’d wager that some types
of immortal cells in people can perform the
same rejuvenating trick to prevent the rDNA
declines that come with age.

7. Vol. 02 NO 8 February 20th, 2018.
7
IIT Madras Student
Launches “IIT Startups”
in San Fransisco
An Indian Institute of Technology Madras
alumnus, Monishi Sanyal has now launched a
non-profit accelerator at the Bay Area in San
Francisco. Called “IIT Startups”, the acceler-
ator seeks to motivate and support budding
entrepreneurs. The initiative will also help to
connect the IIT alumni at the Silicon Valley
in America.
The accelerator was recently launched at
the Computer History Museum, Mountain
View, California.
The event was attended by over 400 IIT
Startups, Angels, Venture Capitals and Men-
tors, a release from IIT-M said.
A BTech graduate from IIT Madras and the
Governor’s Gold medal Recipient in 1970,
Sanyal hopes this initiative will help bridge
the gap between academics and industry
by providing mentorship and incubation to
Airborne-mediated microbial diseases rep-
resent one of the major challenges to world-
wide public health. A direct approach to pre-
vent the transmission of airborne-mediated
disease is inactivation of the corresponding
airborne pathogens, and in fact the airborne
antimicrobial efficacy of ultraviolet (UV)
light has long been established.
“Unfortunately, conventional germicidal
UV light is also a human health hazard and
can lead to skin cancer and cataracts, which
prevents its use in public spaces,” said lead
author Professor David Brenner, from the
Center for Radiological Research at Colum-
bia University Irving Medical Center. Sever-
al years ago, Professor Brenner and co-au-
thors hypothesized that a narrow spectrum
of ultraviolet light called far-UVC could kill
microbes without damaging healthy tissue.
Now, in the latest study, the team at Colum-
bia University suggests that a special form of
ultraviolet (UV) light may be able to “zap”
flu germs right out of the air.
Quite a long while back, Brenner and his
partners conjectured that a limited range of
bright light called far-UVC could murder
microorganisms without harming solid tis-
sue. “Far-UVC light has an exceptionally
restricted range and can’t infiltrate through
the external dead-cell layer of human skin or
the tear layer in the eye, so it’s not a human
wellbeing risk. But since infections and mi-
croscopic organisms are substantially littler
than human cells, far-UVC light can achieve
their DNA and murder them,” said Brenner,
who is additionally a teacher of ecological
wellbeing sciences at Columbia’s Mailman
School of Public Health.
In their prior investigations, Brenner’s
group shown that far-UVC light was compel-
ling at executing MRSA (methicillin-safe S.
By Disha Padmanabha
budding entrepreneurs, and connect the IIT
Alumni in the Silicon Valley.
“This is the first step in our journey. Our
next initiative would be to run workshops,
provide mentorship, incubation, and connec-
tivity to the 11,000+ IIT communities, advi-
sors, angels and VCs in the Silicon Valley,”
he said. Sanyal added that by 2019, the plan
is to expand the operations by collaborating
with the IIT Research Parks in India.
Prof R Nagarajan, Dean (International and
Alumni Relations), IIT Madras, said “Alum-
ni such as Mr Sanyal have been instrumental
in shaping the best-of-breed entrepreneurial
ecosystem that thrives in Silicon Valley. IITs
have benefited as well from the branding and
networking opportunities.”
aureus) microbes, a typical reason for surgi-
cal injury diseases however not hurt human
or mouse skin.
But recently, Brenner and his colleagues
found that a narrow range of UVC light —
far-UVC light, around 207 to 222 nm —
could kill microorganisms without causing
biological damage to exposed skin.
In the study, the team released aerosolized
H1N1 virus (which is a strain of the flu) into
a test chamber, where it was exposed to very
low doses of the light. As a control, they also
released H1N1 into the chamber without the
light exposure.
They then applied low doses of far-UVC
light, and found that the light efficiently inac-
tivated more than 95 percent of the flu virus
particles — about the same effectiveness as
a conventional germicidal UVC lamp. When
the researchers exposed skin cells to the air-
borne flu viruses that were treated with far-
UVC light, the viruses were not able to infect
the skin cells.
“If our results are confirmed in other set-
tings, it follows that the use of overhead
low-level far-UVC light in public locations
would be a safe and efficient method for
limiting the transmission and spread of air-
borne-mediated microbial diseases, such as
influenza and tuberculosis,” said Brenner.
UV Light that Could Wipe
Out Airborne Flu
Microbes
By Disha Padmanabha

8. Vol. 02 NO 8February 20th, 2018.
8
An Ingestible QR Code
that Helps Deliver Tailored
Medication : Future of
Personalized Medicine
3D printers are all the rage in design and
manufacturing circles right now. And the
general media seem to be enamoured of this
technology too, with reports of 3D printers
being used for anything from cutting the
costs of prototype production to making piz-
zas for astronauts to developing a frickin’
beatin’ heart .
Inkjet printing is undoubtedly very attrac-
tive material deposition and patterning tech-
nology thereby receiving such significant
attention in the recent years. It has been ex-
ploited in biology even, for novel applica-
tions including high throughput screening,
pharmaceutical formulations, medical de-
vices and implants. Moreover, inkjet print-
ing has been implemented in cutting-edge
3D-printing healthcare areas such as tissue
engineering and regenerative medicine.
Now, in a similar application, it has been
used to design and develop edible QR codes
which could on enable a new method for the
production of medicine- one that can be tai-
lored to fit each patient and has the potential
to protect against wrong medication and fake
medicine according to researchers at the Uni-
By Disha Padmanabha
versity of Copenhagen.
Natalja Genina, assistant professor at the
Department of Pharmacy, said, “This tech-
nology is promising because the medical
drug can be dosed exactly the way you want
it to. This gives an opportunity to tailor the
medication according to the patient getting
it.”
The idea is for patients to be able to use
their smartphones to scan the edible QR code
and find out information about the medi-
cation they are about to take. The patient’s
name, drug administration route, expiration
date, manufacturer ID and batch number will
all be embedded in the QR code.
The study noted that additional information
could be included based on the national legis-
lation. Making it a scannable QR code could
also reduce the chances of people taking the
wrong medication, or tricked into taking
fake or expired drugs. These situations will
be even easier to avoid once the team deter-
mines how to get an everyday inkjet printer
to apply the medicine as a QR code.
In the future the researchers hope the edible
substrate can be produced and sent to medi-
cal centers, and that the medicinal ink itself
will be printable on standard inkjet printers.
If different medicines were loaded into the
printer as different colors, it should even be
possible to mix customized drug “cocktails”
through software.
Professor Jukka Rantanen, fellow research-
er on the study, said, “If we are successful
with applying this production method to rel-
atively simple printers, then it can enable
the innovative production of personalized
medicine and rethinking of the whole supply
chain.”
Datalikethedose,thepatient’sname,usebydatedate,manufacturerinfo,andinstructionsonhowtotakethemedicinecouldallappearonasmartphonescreen
whenscanningthemedicine(Credit:UniversityofCopenhagen)
BRISTOL-MYERS SQUIBB,
SIRENAS PEN MULTI-TARGET COLLAB
AGREEMENT
Bristol-Myers Squibb has now entered a
research collaboration involving discovery
work related to some undisclosed therapeutic
targets with San Diego-based Sirenas.
The research collaboration leverages Sire-
nas’ expertise in applying ATLANTIS™, its
data mining technology, to identify such po-
tential drug candidates derived from Sirenas’
proprietary chemical library isolated from
global microbiome collections.
According to the deal, Sirenas will receive
By Disha Padmanabha
an undisclosed up-front payment, funding
for research activities and potential success
fees from Bristol-Myers Squibb. In addition,
Bristol-Myers Squibb has an option to license
compounds identified from the collaborative
efforts under a separate agreement that will
include potential milestones and royalties
paid to Sirenas.
“We believe science-focused biopharma
companies can benefit from our innovative
approaches to access breakthrough chem-
istry in delivering drug candidates for diffi-
cult biological targets,” said Jake Beverage,
PharmD., Co-Founder and CEO of Sirenas.
“We look forward to a fruitful collaboration
with Bristol-Myers Squibb, one of the finest
drug discovery teams in the world, to identify
potential new therapies to treat the world’s
highest unmet medical needs.”
Phil Baran, Ph.D., Co-Founder of Sirenas
added, “Sirenas has built a remarkably ef-
fective platform that combines powerful com-
putational approaches, deep natural prod-
uct expertise, and state of the art synthesis
to rapidly deliver new drug candidates. We
are committed to using computational ap-
proaches like ATLANTIS™ with our partners
to uncover novel therapies from the profound
chemistry hidden in the diversity of nature.”

9. Vol. 02 NO 8 February 20th, 2018.
9
Cervical Cancer
Identifying HPV Assay
Approved by the USFDA
New Jersey-based BD (Becton, Dickinson
and Company) has now received the FDA
nod for its BD Onclarity HPV assay that
detects 14 types of high-risk human papillo-
mavirus (HPV) from specimens collected for
cervical cancer screening or “Pap test” in the
BD SurePath liquid based cytology vial.
In addition, the test can also identify HPV
genotypes 16, 18, and 45—genotypes that
have been associated with the majority of
cervical cancers on a global scale.
Results of the primary screening test could
help to triage patients whose results come up
as abnormal. Together with a physician’s as-
sessment, information gathered from the BD
Onclarity HPV Assay could be instrumental
in clinical decision-making.
The FDA grants pre-market approvals
(PMAs) to class 3 medical devices that,
through scientific evidence and research, as-
sure that the product is safe and effective in
what it is intended to do. Obtaining a PMA
grants the product marketing clearance in the
United States.
The BD Onclarity HPV assay is designed
for specimens collected in the BD SurePath
liquid-based cytology vial for cervical cancer
screening. The test is clinically validated for
use as a primary screening test, for triaging
patients with abnormal Pap test results, and
to be used in combination with a Pap test,
BD said in a statement, adding it aligns with
clinical screening guidelines from the Ameri-
can Cancer Society, the American Society for
Colposcopy and Cervical Pathology, and the
American Society for Clinical Pathology.
“Our goal is to provide laboratories and cli-
nicians worldwide with comprehensive cervi-
cal cancer screening solutions that address
By Disha Padmanabha
the unique needs of individual healthcare
providers and patients,” said Dave Hickey,
president, BD Diagnostics Systems. “The
addition of the BD Onclarity™ HPV assay
to BD’s women’s health and cancer portfo-
lio will enable BD to continue to enhance
the standard of patient care, representing the
next milestone in cervical cancer screening.”
Dr. Thomas C. Wright, Jr., professor emer-
itus of pathology and cell biology at Colum-
bia University noted that “The approval of
the BD Onclarity™ HPV assay provides cli-
nicians and laboratories an FDA-approved
option for HPV primary screening with the
BD SurePath™ liquid based cytology vial.
The BD Onclarity™ HPV assay also aligns
with clinical screening guidelines from the
American Cancer Society, the American So-
ciety for Colposcopy and Cervical Pathology
and the American Society for Clinical Pa-
thology.”
If you are an MSc Immunology candidate
with the relevant experience and looking for
a high paying job, then check out all of the
details of the written exam selection proce-
dure at ICMR as per the information posted
below:
Name of the Position :
Consultant (Scientific) Pre-Clinical opera-
tions
No.of.Posts : 01
Age :
Limited as on date: up to 70 years
Consolidated Emoluments :
Maximum Rs.70,000/- per month depend-
ing upon experience and knowledge
Tenure :
Two Years
Essential Qualifications :
1st Class Master’s Degree in Medical Mi-
crobiology/ Medical Pharmacology/Immu-
nology from a recognized University with
4-6 years of experience in Pharma industry/
Biotech industry /CRO industry / Immunolo-
gy related to clinical research studies / trials.
CONSULTANTS (SCIENTIFIC) POST
VACANT @ ICMR |
SALARY OF RS. 70,000/- P.M.
JOBS
Desirable :
• PhD in Medical pharmacology/medical
microbiology/immunology from a rec-
ognized University
• Strong knowledge of clinical research
process and medical terminology.
• Understanding of GCP/ICH guidelines.
• Knowledge of regulatory requirements
and guidelines governing clinical re-
search.
• Ability to work successfully within a
crossfunctional team
• Good Scientific writing/Communi-
cation skills Knowledge of computer
applications or business intelligence
tools/data management / data synthesis
Nature of Duties:
• To manage all clinical aspects of study
including assessing operational feasi-
bility and recommending study exe-
cution plan; developing and managing
comprehensive study timelines and
metrics
• To participate in Selection and manage-
ment/Oversight of external vendors and
develops vendor specifications; review
vendor reports, budgets and metrics
• To provide study specific training and
leadership to Clinical Research Staff,
including CRO, CRAs, Sites and other
contract personnel
• To plan, Execute and Lead study spe-
cific meetings
• To participate in Site monitoring visits
and oversee clinical monitoring activ-
ities ensuring compliance with Good
Clinical Practices
• To prepare and/or review study relat-
ed Standard Operating procedures and
Documents
• To develop and manage study budget
and maintain it within financial goals
• The job may require travel to the trial
sites and attending outstation meetings
Selection Procedure:
• Interview will be conducted to the el-
igible candidates. However, if more
number of candidates are found eli-
gible for the post advertised, Written
Test/ Skill Test may also be
• conducted on the same day before final
round of Interview.
• The candidates should bring 5 copies
of biodata along with all original cer-
tificates of educational qualifications
(from SSC onwards), experience,
Aadhaar Card, Community and PH
Certificates along with one set of pho-
tocopies of the same duly attested (can
be self attested) along with a passport
size photograph for attending the Writ-
ten Test/ Interview.
• No TA/ DA will be paid for attending
the Written Test/ Interview. The recruit-
ed project staff is eligible for leave as
per rules and will have to give an un-
dertaking before joining.
Interested candidates for the various posi-
tions mentioned below are invited to appear
for the Walk-in-Written Test/ Interview as
mentioned for the various positions along
with 5 copies of their updated Bio data/CV
on the respective dates indicated against the
notified positions reporting strictly between
09:00 A.M to 10:00 A.M at the following ad-
dress :
Reception hall,
Indian Council of Medical Research,
Ramalingaswami Bhawan,
Ansari Nagar New Delhi-110 029
Date & Time of Written Test/
Interview : 24 February 2018 strictly
between 09:00 A.M to 10:00 A.M

10. Vol. 02 NO 8February 20th, 2018.
10
Applications are invited for the position of
Junior Research Fellow/Senior Research Fel-
low (Project) for the following time-bound
sponsored project and if you have an MSc or
M.Tech degree then apply as per the details
given below:
Job Title : Junior Research Fellow/Sen-
ior Research Fellow (Project)
No.of.Posts : 1
Project Title :
“Cancer Research Program” funded by
DBT
Principal Investigator :
Dr. Anil K. Suri Professor of Eminence (
aks@nii.ac.in )
ACTREC is hiring for a Junior Research
Fellow position and if you have an MSc de-
gree in Life sciences, then you are eligible
to attend the walk-in interview that has been
scheduled for the position whose details are
listed below:
Job Title: Junior Research Fellow
No.of.Posts : 01
Name of the Project :
To Evaluate the Role of γδ-T cells in
Colorectal Cancer
Principal Investigator :
Dr.S.V.Chiplunkar
Funding Agency :
CANCER RESEARCH PROGRAM PROJECT
POSTS @ NII
RESEARCH OPPORTUNITY FOR MSC LIFE
SCIENCES CANDIDATES @ ACTREC
Emolument:
The selected candidates may be placed in
any of the below categories depending upon
qualification & experience.
Junior Research Fellow :
Rs. 25,000/- consolidated p.m. plus 30%
HRA
Senior Research Fellow :
Rs. 28,000/- consolidated p.m. plus 30%
HRA
Qualifications:
• Junior Research Fellow : M.Sc or
equivalent degree in the Biological
Sciences.
• Senior Research Fellow : M.Sc/M.Tech
in Life sciences with two years of re-
Bristol-Myers Squibb Biocon Research
Center (BBRC) & ACTREC.
Duration :
One year from the date of appointment
Consolidated Salary :
Rs. 20,000/- per month.
The work progress of the candidate will be
monitored and extension after 6 months will
depend on satisfactory progress of the work.
Qualification:
Post graduate degree (MSc.) with minimum
60% marks in Life science or related fields
from a recognized university. Candidate
should have at least one year experience in
cell culture techniques, immunological tech-
search experience.
PS- The Candidate should have qualified
any ‘National Level Examination’ such as
NET/ GATE etc for applying the above po-
sition.
Job Description & Desired Knowledge:
• Junior Research Fellow : Candidates
should have knowledge of Molecular
Biology techniques, Recombinant pro-
tein technology, cell culture, RT-PCR
and Cancer Immunology
• Senior Research Fellow : Candidates
should have experience in Cancer Cell
line culture, Immunohistochemistry,
Real Time PCR, Western Blotting and
animal handling.
niques, handling patient samples, molecular
biology techniques etc.
*One year M.Sc. degree course will not be
considered.
Selected candidate will have to join at the
earliest; hence results-awaited candidates
will not be eligible to apply for the post.
Application Format:
Candidates fulfilling these requirements
should pre-register by sending their applica-
tion in the prescribed format with recent CV
and contact details of 2 referees by e-mail to
the ‘academic.office@actrec.gov.in’ latest by
17.00 hrs on 23rd February 2018.
The interviews would be held on 28/02/2018
and will be only for the pre-registered can-
didates. Candidates should report between
09.30 to 10.00 a.m. at 3rd floor, Paymaster
How to Apply:
Interested candidates may apply directly,
STRICTLY IN THE PRESCRIBED FOR-
MAT GIVEN BELOW, through e-mail, to the
Investigator of the project, clearly indicating
the name of the project along with their com-
plete C.V., e-mail id, fax numbers, telephone
numbers. Only Short listed candidates will be
called for interview and they required to sub-
mit attested copies of all their certificates and
a Demand Draft of Rs 100/- drawn on Ca-
nara Bank or Indian Bank payable at Delhi/
New Delhi in favour of the Director, NII (SC/
ST/PH and Women candidates are exempted
from payment of fees) subject to submission
of documentary proof), at the time of inter-
view.
Application Deadline – 28th February,
2018
Shodhika, ACTREC, Kharghar, Navi Mum-
bai. No T.A. /D.A. will be admissible for at-
tending the interview.
At the time of Interview the candidate
should bring original certificates along with
CV with contact details of 2 referees and sub-
mit the photocopies (attested) of the certifi-
cates, with a recent passport size photograph.
All correspondence should be strictly
made only to
academic.office@actrec.gov.in’ as
indicated.
Walk-In Details:
Application Deadline – 23rd February
2018.
Date of Interview – 28th February 2018
Reporting Time – 09.30 to 10.00 a.m.

11. Vol. 02 NO 8 February 20th, 2018.
11
BioTecNika Info Labs Pvt Ltd – Parent
Company which runs India’s Largest Bio-
sciences Career & education Portal is looking
for passionate candidates having sound aca-
demic qualifications, Excellent Communi-
cation skills & Teaching Experience, willing
to join India’s Largest Biosciences Career &
Education Portal www.biotecnika.org as Ac-
ademic Support Specialist at Noida location
Job seekers with an MSc background in
Plant protection like Entomology/ Patholo-
gy/ Microbiology and related subjects with
relevant experience can apply online for a
Scientific Officer position that is available
at ICRISAT. Check out all the details posted
below on the same:
ICRISAT invites applications from dynamic
nationals for the position a Scientific Officer
– ISD Program. This position is based at IC-
RISAT’s Headquarters, Hyderabad India.
ICRISAT is headquartered in Patancheru
near Hyderabad, India, with two regional
hubs and five country offices in sub-Saharan
Africa. ICRISAT, established in 1972, is a
member of the CGIAR Consortium.
Job Title : Scientific Officer – ISD Pro-
gram
Responsibilities:
Coordination of picture collection and im-
age database development
• Coordinate the extension of picture da-
tabase on agronomic stresses and crops
that can be found in South India (main-
ly Telangana & Andhra Pradesh)
• Hiring and training of field staff (pic-
ture collectors)
• Monitor activities of field staff and
provide reports on regular basis to the
Scientist
• Picture database maintenance by using
a web based tool (web App)
LIFE SCIENCE LECTURER / PROFESSOR
POST VACANT @ BIOTECNIKA – NOIDA &
CHENNAI
SCIENTIFIC OFFICER POST FOR
MSC CANDIDATES @ ICRISAT
Name of the Position :
Academic Support Specialist ( CSIR
QUALIFICATION IS A MUST )
Reference Code : JGJG – ASS182
• Identification of important plant dis-
eases, pests and nutrient deficiencies as
well as crop stages
Training and capacity building
• Participation and conduct training pro-
grams with the Scientist to educate
farmers, picture collectors, and other
stakeholders in the handling of the dif-
ferent Plantix versions
• Maintenance of training records and
follow up as per requirement and guid-
ance of the Scientist
Plantix App improvement and dissemi-
nation
• Support and user field testing and the
conduct user surveys
• Collect and process relevant agricultur-
al information to enhance the usability
of new features
• Establish a network of agricultural ex-
perts and consultants to receive feed-
back on the Plantix App and commu-
nication
• Organize and implement regular user
testing with farmers – results should be
processed and transferred to the head-
quarter
• Dissemination of Plantix in India due
to activities like presentations of Plan-
tix to third parties and coordination of
meetings with different stakeholders,
e.g. agricultural institutions, research
centers, government officials, public
and private companies, NGOs, farmer
Location :
Noida, Chennai
Salary range :
Rs 2 Lakh Per Annum to 6 lakh Per annum
+ Attractive Monthly Incentives
groups, etc.
Follow up of core activities
• Should be active in taking forward all
the activities taken up as a part of work
delegated by the Scientist which may
be dynamic in nature with smaller turn-
around times
• Provide regular feedback on progress
of activities and perform activity man-
agement across other partner projects
• Any other activity that evolves dur-
ing the course of the project including
project management, coordination and
documentation needs
Essential Criteria:
• Master’s degree in Plant protection like
Entomology/ Pathology/ Microbiology
and related subjects
• Good written and oral communications
skills in English and Telugu
• Willingness and aptitude to quickly
learn and use new technologies
• Prior experience in agriculture or allied
sectors and working directly with farm-
ers and farmer groups (above 2 years)
Desirable:
• Candidate should be tech savvy and
should not be reluctant in handling of
new tools like mobile phone applica-
tions and web based apps
• Should be fluent in Telugu and English
(written and spoken) with excellent
Why Work at BioTecNika ?
If you are looking for a long term stable ca-
reer in BT industry and want to rub shoulders
with the biggest names in Biotech, then Bio-
TecNika should be your destination. A Com-
pany Supported by Biotech veterans & Ven-
ture Capitalists, Biotecnika has a long way to
go and we are looking for you.
communication skills
• A proactive and independent approach
to work with good experience in mul-
ti-stakeholder project coordination.
• Experience in organizing capacity
building programs especially digitiza-
tion related in Agriculture
• Hands on experience of on-farm farmer
participatory action research trials
• Expertise in MS word, power points,
excel, Share Point is desirable
• Knowledge on how the application of
Digital Agriculture may enhance pro-
ductivity, logistics or market access for
smallholder farmers and value chain
actors.
General:
This is a Locally Recruited Staff (LRS) po-
sition for two years renewable based on the
performance of the incumbent and the insti-
tute’s continuing need for the position.
How to Apply:
Applicants should apply on or before 28
February 2018, with a letter of motivation,
latest Curriculum Vitae, and names and con-
tact information of three references that are
knowledgeable of the candidate’s profession-
al qualifications and work experience. All
applications will be acknowledged. Howev-
er, only short-listed candidates will be con-
tacted.
Application Deadline – on or before
28/02/2018

12. Vol. 02 NO 8February 20th, 2018.
12
Candidates from an MTech Biotechnology
background are invited for the position of
senior research fellow and the University in-
vites applications (Priced Rs.50/=) to be ob-
tained from the Information Section for the
position in the DAE sponsored BRNS Re-
search Scheme as per the details given below:
Name of the Position : Senior Research
Fellow
No.of.Posts : 01
Project Title :
“Development of Efficient Biomass Con-
version Routes for Biofuel Production and
Utilization”
RESEARCH POSITION FOR BIOTECH
CANDIDATES VACANT
@ JADAVPUR UNIVERSITY
Age :
Not more than 32 years (Relaxable up to 5
years in case of SC/ST/OBC/ Women /PH
candidates).
Fellowship :
Rs. 28000/-+ HRA @ 30% per month
Tenure :
Till 31 st March, 2020 or termination of the
project
Essential Qualification :
Candidates must have a first class M.E./M.
Tech. degree in Bioprocess Engineering/Bio-
technology or Allied subjects from a reputed
university with at least two years research ex-
perience in the field of generation of biofuels.
Desirable Qualifications :
(1) Practical knowledge on using poly-cul-
ture for the generation of biofuels;
(2) Practical and theoretical knowledge on
microbial interaction
(3) should have 2 publications in reputed
scientific journals of impact factor of at least
2.
Application Instructions :
Interested and eligible candidates may apply
for the post and appear in person directly in
the interview with application on prescribed
forms (priced Rs/-50) to be obtained from the
Information section of Jadavpur University.
Originals along with attested copies of mark-
sheets, certificates and testimonials are to be
produced at the time of interview. Selected
candidates will not be entitled to claim for
regular appointment/absorption in this insti-
tute.
No TA/DA is admissible for the interview.
Walk-In Details:
• Date of Interview – 21st February,
2018
• Time of Interview – 11:00 AM
• Venue of Interview – Office of Prof.
Ranjana Chowdhury, Chemical En-
gineering Department, Jadavpur
University, Kolkata, India
www.biotecnika.org